Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
Drug and Chemical Toxicology|January 1, 1984
Tulobuterol: one-month intravenous safety studies in rats and dogsF L Fort, C L Yang, M C Pratt, et al.
Neurology|December 1, 1993
The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's diseaseJ C Morris, S Edland, C Clark, et al.
Molecular and Cellular Biology|October 1, 1995
9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activationR P Bissonnette, T Brunner, S B Lazarchik, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1996
Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptorsA M Standeven, R L Beard, A T Johnson, et al.
The Journal of Clinical Investigation|May 18, 2004
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1cMitsuhiro Watanabe, Sander M Houten, Li Wang, et al.
Stroke|July 1, 1984
The pilot Stroke Data Bank: definition, design, and dataS C Kunitz, C R Gross, A Heyman, et al.
Neurology|January 1, 1995
The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's diseaseP C Davis, M Gearing, L Gray, et al.
Toxicology and Applied Pharmacology|August 1, 1985
Acute, subchronic, and chronic toxicity studies with 3-O-demethylfortimicin A disulfate, a new aminocyclitol antibioticE T Kimura, S Tekeli, M C Pratt, et al.
Multiple Sclerosis and Related Disorders|October 18, 2021
Infection incidence and management in multiple sclerosis patients after initiating disease-modifying therapyElizabeth C S Swart, Douglas Mager, Natasha Parekh, et al.
Neurology|June 1, 1987
Early-onset Alzheimer's disease: clinical predictors of institutionalization and deathA Heyman, W E Wilkinson, B J Hurwitz, et al.
Pageof 27